Cole Douglas G. Insider Trades

Insider Trading History

Track insider trading activity for Cole Douglas G.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $104k 25,000 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$120k 25,000 shares
$4.79
$4.14
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$88.3k 16,000 shares
$5.52
$4.14
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $182k 54,278 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$399k 54,278 shares
$7.36
$3.35
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $218k 65,000 shares
Last Trade
Jun 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 65,000 shares
$7.36
$3.35
Sigilon Therapeutics
Sigilon Therapeutics SGTX
Director
Holding Value $0 0 shares
Last Trade
Aug 11, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$15.3k 683 shares
$22.47
$22.47
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 16,000 shares
$8.70
$4.14
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $218k 65,000 shares
Last Trade
Jun 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 65,000 shares
$6.70
$3.35
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $658k 26,564 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 12,649 shares
$30.92
$24.77
Sigilon Therapeutics
Sigilon Therapeutics SGTX
Director
Holding Value $200k 8,888 shares
Last Trade
May 19, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$956k 8,888 shares
$107.58
$22.47
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $66.2k 16,000 shares
Last Trade
Jun 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 16,000 shares
$13.81
$4.14
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $218k 65,000 shares
Last Trade
Jun 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$322k 65,000 shares
$4.95
$3.35
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $554k 22,348 shares
Last Trade
Jun 02, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$145k 5,986 shares
$24.27
$24.77
Sigilon Therapeutics
Sigilon Therapeutics SGTX
Director
Holding Value $200k 8,888 shares
Last Trade
May 26, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.29M 17,776 shares
$128.98
$22.47
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Director
Holding Value $51.9k 12,530 shares
Last Trade
Jul 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$118k 12,530 shares
$9.40
$4.14
Sigilon Therapeutics
Sigilon Therapeutics SGTX
Director
Holding Value $200k 8,888 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15M 8,888 shares
$1,684.93
$22.47
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $154k 6,222 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$529k 8,296 shares
$63.76
$24.77
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $80.6k 3,253 shares
Last Trade
Jun 01, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 3,253 shares
$61.59
$24.77
Denali Therapeutics
Denali Therapeutics DNLI
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$200k 3,253 shares
$61.59
$24.77
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $79k 23,591 shares
Last Trade
Feb 03, 2021 Sale (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.35
Sana Biotechnology
Sana Biotechnology SANA
Director
Holding Value $46.9k 14,000 shares
Last Trade
Feb 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$3.35

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up